View ValuationJaysynth Orgochem 将来の成長Future 基準チェック /06現在、 Jaysynth Orgochemの成長と収益を予測するのに十分なアナリストの調査がありません。主要情報n/a収益成長率n/aEPS成長率Chemicals 収益成長19.4%収益成長率n/a将来の株主資本利益率n/aアナリストカバレッジNone最終更新日n/a今後の成長に関する最新情報更新なしすべての更新を表示Recent updatesValuation Update With 7 Day Price Move • Apr 06Investor sentiment improves as stock rises 31%After last week's 31% share price gain to ₹12.63, the stock trades at a trailing P/E ratio of 14.1x. Average trailing P/E is 20x in the Chemicals industry in India. Total returns to shareholders of 166% over the past three years.New Risk • Apr 01New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Indian stocks, typically moving 8.6% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Paying a dividend despite having no free cash flows. Share price has been volatile over the past 3 months (8.6% average weekly change). Market cap is less than US$100m (₹1.46b market cap, or US$15.7m).Reported Earnings • Feb 23Third quarter 2026 earnings released: EPS: ₹0.17 (vs ₹0.40 in 3Q 2025)Third quarter 2026 results: EPS: ₹0.17 (down from ₹0.40 in 3Q 2025). Revenue: ₹659.4m (up 9.2% from 3Q 2025). Net income: ₹23.3m (down 57% from 3Q 2025). Profit margin: 3.5% (down from 9.0% in 3Q 2025). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 109% per year but the company’s share price has only increased by 35% per year, which means it is significantly lagging earnings growth.Reported Earnings • Nov 13Second quarter 2026 earnings released: EPS: ₹0.37 (vs ₹0.31 in 2Q 2025)Second quarter 2026 results: EPS: ₹0.37 (up from ₹0.31 in 2Q 2025). Revenue: ₹673.8m (up 17% from 2Q 2025). Net income: ₹49.5m (up 17% from 2Q 2025). Profit margin: 7.3% (down from 7.4% in 2Q 2025). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 117% per year but the company’s share price has only increased by 30% per year, which means it is significantly lagging earnings growth.Upcoming Dividend • Sep 08Upcoming dividend of ₹0.05 per shareEligible shareholders must have bought the stock before 12 September 2025. Payment date: 18 October 2025. Payout ratio is a comfortable 4.3% and this is well supported by cash flows. Trailing yield: 0.3%. Lower than top quartile of Indian dividend payers (1.3%). Lower than average of industry peers (0.7%).お知らせ • Aug 25+ 2 more updatesJaysynth Orgochem Limited to Report Q3, 2026 Results on Feb 14, 2026Jaysynth Orgochem Limited announced that they will report Q3, 2026 results on Feb 14, 2026Declared Dividend • Aug 25Dividend of ₹0.05 announcedDividend of ₹0.05 is the same as last year. Ex-date: 12th September 2025 Payment date: 19th October 2025 Dividend yield will be 0.3%, which is lower than the industry average of 0.8%. Sustainability & Growth Dividend is well covered by both earnings (4% earnings payout ratio) and cash flows (19% cash payout ratio). The company is yet to establish a track record of dividend growth or stability as it hasn't paid a regular dividend for at least 2 years. Earnings per share has grown by 32% over the last 5 years. Unless this trend reverses, it should provide support to the dividend and adequate earnings cover.Reported Earnings • Aug 12First quarter 2026 earnings released: EPS: ₹0.13 (vs ₹0.21 in 1Q 2025)First quarter 2026 results: EPS: ₹0.13 (down from ₹0.21 in 1Q 2025). Revenue: ₹590.1m (up 17% from 1Q 2025). Net income: ₹17.2m (down 40% from 1Q 2025). Profit margin: 2.9% (down from 5.7% in 1Q 2025). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 104% per year but the company’s share price has only increased by 46% per year, which means it is significantly lagging earnings growth.お知らせ • Aug 11Jaysynth Orgochem Limited, Annual General Meeting, Sep 19, 2025Jaysynth Orgochem Limited, Annual General Meeting, Sep 19, 2025.お知らせ • Aug 02Jaysynth Orgochem Limited to Report Q1, 2026 Results on Aug 11, 2025Jaysynth Orgochem Limited announced that they will report Q1, 2026 results on Aug 11, 2025Reported Earnings • May 29Full year 2025 earnings released: EPS: ₹1.16 (vs ₹0.91 in FY 2024)Full year 2025 results: EPS: ₹1.16 (up from ₹0.91 in FY 2024). Revenue: ₹2.31b (up 9.3% from FY 2024). Net income: ₹156.2m (up 27% from FY 2024). Profit margin: 6.7% (up from 5.8% in FY 2024). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 89% per year but the company’s share price has only increased by 46% per year, which means it is significantly lagging earnings growth.お知らせ • May 28Jaysynth Orgochem Limited Recommends Dividend for the Financial Year Ended 31 March 2025Jaysynth Orgochem Limited announced that at its board meeting held on 28 May 2025, recommended the payment of dividend for the financial year ended 31 March 2025 at 5% that is INR 0.05 per equity shares having face value of INR 1 each, subject To Approve the Members at the upcoming Annual General Meeting of the Company.お知らせ • May 19Jaysynth Orgochem Limited to Report Q4, 2025 Results on May 28, 2025Jaysynth Orgochem Limited announced that they will report Q4, 2025 results on May 28, 2025New Risk • May 19New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Indian stocks, typically moving 8.5% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Share price has been volatile over the past 3 months (8.5% average weekly change). Market cap is less than US$100m (₹3.24b market cap, or US$37.9m).Valuation Update With 7 Day Price Move • May 16Investor sentiment improves as stock rises 17%After last week's 17% share price gain to ₹22.24, the stock trades at a trailing P/E ratio of 20x. Average trailing P/E is 26x in the Chemicals industry in India. Total returns to shareholders of 201% over the past three years.Reported Earnings • Feb 13Third quarter 2025 earnings released: EPS: ₹0.40 (vs ₹0.32 in 3Q 2024)Third quarter 2025 results: EPS: ₹0.40 (up from ₹0.32 in 3Q 2024). Revenue: ₹618.7m (up ₹616.4m from 3Q 2024). Net income: ₹54.6m (up ₹50.3m from 3Q 2024). Profit margin: 8.8% (down from 182% in 3Q 2024). Over the last 3 years on average, earnings per share has increased by 69% per year whereas the company’s share price has increased by 65% per year.お知らせ • Feb 04Jaysynth Orgochem Limited to Report Q3, 2025 Results on Feb 12, 2025Jaysynth Orgochem Limited announced that they will report Q3, 2025 results on Feb 12, 2025Valuation Update With 7 Day Price Move • Jan 20Investor sentiment improves as stock rises 16%After last week's 16% share price gain to ₹27.82, the stock trades at a trailing P/E ratio of 28.6x. Average trailing P/E is 30x in the Chemicals industry in India. Total returns to shareholders of 447% over the past three years.お知らせ • Nov 04Jaysynth Orgochem Limited to Report Q2, 2025 Results on Nov 12, 2024Jaysynth Orgochem Limited announced that they will report Q2, 2025 results on Nov 12, 2024Valuation Update With 7 Day Price Move • Oct 14Investor sentiment improves as stock rises 16%After last week's 16% share price gain to ₹20.35, the stock trades at a trailing P/E ratio of 20x. Average trailing P/E is 35x in the Chemicals industry in India. Total returns to shareholders of 240% over the past three years.お知らせ • Sep 24Jaysynth Orgochem Limited Announces Cessation of Trikamdas Chandan as Independent DirectorJaysynth Orgochem Limited informed that Umesh Trikamdas Chandan (DIN: 00184677) ceased to be an Independent Director of the Company upon completion of his second term of 5 (Five) consecutive years w.e.f. closure of business hours on 23rd September, 2024.Upcoming Dividend • Sep 11Upcoming dividend of ₹0.05 per shareEligible shareholders must have bought the stock before 18 September 2024. Payment date: 26 October 2024. Payout ratio is a comfortable 5.5% and this is well supported by cash flows. Trailing yield: 0.3%. Lower than top quartile of Indian dividend payers (1.0%). Lower than average of industry peers (0.6%).お知らせ • Aug 29+ 1 more updateJaysynth Orgochem Limited, Annual General Meeting, Sep 26, 2024Jaysynth Orgochem Limited, Annual General Meeting, Sep 26, 2024.Valuation Update With 7 Day Price Move • Aug 21Investor sentiment improves as stock rises 15%After last week's 15% share price gain to ₹19.35, the stock trades at a trailing P/E ratio of 19x. Average trailing P/E is 35x in the Chemicals industry in India. Total returns to shareholders of 198% over the past three years.Buy Or Sell Opportunity • Aug 06Now 21% undervaluedOver the last 90 days, the stock has risen 25% to ₹15.66. The fair value is estimated to be ₹19.93, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 158% over the last 3 years. Meanwhile, the company has become profitable.お知らせ • Aug 03Jaysynth Orgochem Limited to Report Q1, 2025 Results on Aug 13, 2024Jaysynth Orgochem Limited announced that they will report Q1, 2025 results on Aug 13, 2024Buy Or Sell Opportunity • Jul 08Now 22% overvalued after recent price riseOver the last 90 days, the stock has risen 172% to ₹21.22. The fair value is estimated to be ₹17.45, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 158% over the last 3 years. Meanwhile, the company has become profitable.Valuation Update With 7 Day Price Move • Jun 29Investor sentiment improves as stock rises 21%After last week's 21% share price gain to ₹16.80, the stock trades at a trailing P/E ratio of 18.4x. Average trailing P/E is 34x in the Chemicals industry in India. Total returns to shareholders of 433% over the past three years.Valuation Update With 7 Day Price Move • Jun 12Investor sentiment improves as stock rises 16%After last week's 16% share price gain to ₹13.83, the stock trades at a trailing P/E ratio of 15.2x. Average trailing P/E is 32x in the Chemicals industry in India. Total returns to shareholders of 355% over the past three years.お知らせ • May 31JD Orgochem Limited Proposes Dividend for the Financial Year Ended 31 March, 2024JD Orgochem Limited announced that Board of Directors of the Company at its Meeting held on 29th May, 2024, recommended payment of Dividend for the financial year ended 31st March, 2024 @ 5% i.e. 0.05 per equity shares having face value of 1/- each, subject To Approve the Members at the Annual General Meeting of the Company.お知らせ • May 30Jd Orgochem Limited Announces Resignation of Bharati Ravindra Chandan and Mitesh Dilip Sejpal from the Position of Non-Executive Independent DirectorJD Orgochem Limited at its Board Meeting held on 29th May, 2024, resignation of Bharati Ravindra Chandan and Mitesh Dilip Sejpal from the position of Non-Executive Independent Director of the Company effective 29th May, 2024.お知らせ • May 23JD Orgochem Limited to Report Q4, 2024 Results on May 29, 2024JD Orgochem Limited announced that they will report Q4, 2024 results on May 29, 2024New Risk • May 10New major risk - Shareholder dilutionThe company's shareholders have been substantially diluted in the past year. Over 9x increase in shares outstanding. This is considered a major risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-₹38m free cash flow). Negative equity (-₹266m). Earnings have declined by 54% per year over the past 5 years. Shareholders have been substantially diluted in the past year (over 9x increase in shares outstanding). Revenue is less than US$1m (₹7.5m revenue, or US$89k). Minor Risks Share price has been volatile over the past 3 months (9.1% average weekly change). Market cap is less than US$100m (₹1.69b market cap, or US$20.3m).お知らせ • Feb 05JD Orgochem Limited to Report Q3, 2024 Results on Feb 13, 2024JD Orgochem Limited announced that they will report Q3, 2024 results at 3:30 PM, Indian Standard Time on Feb 13, 2024New Risk • Nov 15New major risk - Share price stabilityThe company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Indian stocks, typically moving 9.0% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-₹38m free cash flow). Share price has been highly volatile over the past 3 months (9.0% average weekly change). Negative equity (-₹266m). Earnings have declined by 61% per year over the past 5 years. Revenue is less than US$1m (₹1.0m revenue, or US$12k). Market cap is less than US$10m (₹99.8m market cap, or US$1.20m).Reported Earnings • Nov 12Second quarter 2024 earnings released: ₹0.07 loss per share (vs ₹5.15 loss in 2Q 2023)Second quarter 2024 results: ₹0.07 loss per share (improved from ₹5.15 loss in 2Q 2023). Revenue: ₹3.70m (down 7.0% from 2Q 2023). Net loss: ₹1.03m (loss narrowed 99% from 2Q 2023). Over the last 3 years on average, earnings per share has fallen by 61% per year but the company’s share price has increased by 34% per year, which means it is well ahead of earnings.お知らせ • Nov 01JD Orgochem Limited to Report Q2, 2024 Results on Nov 09, 2023JD Orgochem Limited announced that they will report Q2, 2024 results on Nov 09, 2023お知らせ • Sep 28JD Orgochem Limited Appoints Maitri Bhayani as Company Secretary and Compliance OfficerJD Orgochem Limited has appointed Ms. Maitri Bhayani (Membership No. A68431) Member of Institute of Company Secretaries of India as Company Secretary and Compliance Officer of the Company with effect from 27th September, 2023. Ms. Maitri Bhayani (Membership No. A68431) is an associate member of the Institute of Company Secretaries of India and is also Commerce Graduate. She possesses over 2 years of post qualification experience. She has vast exposure in dealing with compliances of Public and Private Companies.お知らせ • Aug 09JD Orgochem Limited, Annual General Meeting, Sep 25, 2023JD Orgochem Limited, Annual General Meeting, Sep 25, 2023.Reported Earnings • Aug 09First quarter 2024 earnings released: ₹0.25 loss per share (vs ₹0.06 profit in 1Q 2023)First quarter 2024 results: ₹0.25 loss per share (down from ₹0.06 profit in 1Q 2023). Revenue: ₹421.0k (down 90% from 1Q 2023). Net loss: ₹3.25m (down 491% from profit in 1Q 2023). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 99 percentage points per year, which is a significant difference in performance.お知らせ • Aug 01JD Orgochem Limited to Report Q1, 2024 Results on Aug 08, 2023JD Orgochem Limited announced that they will report Q1, 2024 results on Aug 08, 2023お知らせ • May 06JD Orgochem Limited to Report Q4, 2023 Results on May 12, 2023JD Orgochem Limited announced that they will report Q4, 2023 results on May 12, 2023お知らせ • Feb 11JD Orgochem Limited Announces Resignation of Shivani S. Kawle as Company Secretary and Compliance Officer, Effective March 31, 2023JD Orgochem Limited announced that Ms. Shivani S. Kawle has tendered her resignation from the post of Company Secretary and Compliance Officer (Key Managerial Personnel) of the Company. The Company has accepted her resignation and relieved her from duties with effect from close of business hours of 31st March, 2023. She tendered her resignation to pursue opportunities outside the Company.お知らせ • Feb 03JD Orgochem Limited to Report Q3, 2023 Results on Feb 10, 2023JD Orgochem Limited announced that they will report Q3, 2023 results on Feb 10, 2023お知らせ • Jan 26JD Orgochem Limited (BSE:524592) entered into a scheme of implementation to acquire Jaysynth Dyestuff (India) Limited and Jaysynth Impex Private Limited.JD Orgochem Limited (BSE:524592) entered into a scheme of implementation to acquire Jaysynth Dyestuff (India) Limited and Jaysynth Impex Private Limited on January 24, 2023. As per the terms, JD Orgochem will issue 14 fully paid up equity shares JD Orgochem allotted for every 1 share held by the Equity Shareholders of Jaysynth Dyestuff (India) Limited, and 252 fully paid up 2% Redeemable Non-convertible Non-Cumulative Non-Participating Preference Shares of JD Orgochem to be issued and allotted for every 1 each held by the Equity Shareholders of Jaysynth Impex Private.Board Change • Nov 17Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 4 experienced directors. 2 highly experienced directors. Whole Time Director Suhas Jande was the last director to join the board, commencing their role in 2019. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.お知らせ • Nov 03JD Orgochem Limited to Report Q2, 2023 Results on Nov 10, 2022JD Orgochem Limited announced that they will report Q2, 2023 results on Nov 10, 2022お知らせ • Jul 30JD Orgochem Limited to Report Q1, 2023 Results on Aug 08, 2022JD Orgochem Limited announced that they will report Q1, 2023 results at 12:00 PM, Indian Standard Time on Aug 08, 2022お知らせ • Jul 13JD Orgochem Limited, Annual General Meeting, Aug 08, 2022JD Orgochem Limited, Annual General Meeting, Aug 08, 2022, at 15:00 Indian Standard Time.お知らせ • May 21JD Orgochem Limited to Report Q4, 2022 Results on May 30, 2022JD Orgochem Limited announced that they will report Q4, 2022 results on May 30, 2022Board Change • Apr 27Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 6 experienced directors. No highly experienced directors. Whole Time Director Suhas Jande was the last director to join the board, commencing their role in 2019. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.Board Change • Apr 02Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 6 experienced directors. No highly experienced directors. Whole Time Director Suhas Jande was the last director to join the board, commencing their role in 2019. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.Reported Earnings • Feb 13Third quarter 2022 earnings: Revenues and EPS in line with analyst expectationsThird quarter 2022 results: ₹0.13 loss per share (up from ₹0.24 loss in 3Q 2021). Revenue: ₹9.46m (up 224% from 3Q 2021). Net loss: ₹1.81m (loss narrowed 42% from 3Q 2021). Revenue was in line with analyst estimates. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 94 percentage points per year, which is a significant difference in performance.お知らせ • Feb 11JD Orgochem Limited Announces Appointment of Shivani Shailesh Kawle as Company Secretary and Compliance OfficerJD Orgochem Limited announced at the board meeting held on February 10, 2022 that the company approved appointment Ms. Shivani Shailesh Kawle Member of Institute of Company Secretaries of India as Company Secretary and Compliance Officer of the Company with effect from 10 February, 2022.お知らせ • Feb 03JD Orgochem Limited to Report Q3, 2022 Results on Feb 10, 2022JD Orgochem Limited announced that they will report Q3, 2022 results on Feb 10, 2022Reported Earnings • Jul 04Full year 2021 earnings released: ₹0.67 loss per share (vs ₹0.86 loss in FY 2020)The company reported a solid full year result with reduced losses, improved revenues and improved control over expenses. Full year 2021 results: Revenue: ₹19.8m (up 32% from FY 2020). Net loss: ₹8.52m (loss narrowed 25% from FY 2020). Over the last 3 years on average, earnings per share has fallen by 61% per year but the company’s share price has increased by 7% per year, which means it is well ahead of earnings.Is New 90 Day High Low • Feb 18New 90-day low: ₹2.81The company is down 6.0% from its price of ₹2.99 on 19 November 2020. The Indian market is up 21% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 15% over the same period.お知らせ • Feb 13JD Orgochem Limited Announces Appointment of Kantibhai Maganbhai Darji as Chief Financial Officer and Key Managerial PersonnelJD Orgochem Limited announced that at its Board meeting held on 11th February, 2021, approved the appointment of Kantibhai Maganbhai Darji as Chief Financial Officer and Key Managerial Personnel of the Company. Mr. Kantibhai Maganbhai Darji has been appointed as Chief Financial Officer (CFO)and Key Managerial Personnel (KMP) of the Company with effect from 11th February, 2021. Mr. Kantibhai Maganbhai Darji is a commerce graduate & possesses over 30 years of experience across various fields such as banking, finance, fund management, budgeting etc. He is well conversant with the industry, commerce and trade.お知らせ • Feb 02JD Orgochem Limited to Report Q3, 2021 Results on Feb 11, 2021JD Orgochem Limited announced that they will report Q3, 2021 results on Feb 11, 2021Is New 90 Day High Low • Dec 23New 90-day high: ₹3.13The company is up 4.0% from its price of ₹3.02 on 18 September 2020. The Indian market is up 19% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 18% over the same period.お知らせ • Dec 18JD Orgochem Limited Announces the Resignation of Narendra Ramanlal Shah from Key Managerial PersonnelJD Orgochem Limited announced that Narendra Ramanlal Shah, Chief Financial Officer and Key Managerial Personnel of the Company, has tendered his resignation dated 15th December, 2020 and he will be relieved from the duties with effect from closing hours of 31st December, 2020. The company is in the process of appointing a new Chief Financial Officer and same will be communicated to the Stock Exchange in due course.お知らせ • Dec 17JD Orgochem Limited Announces the Resignation of Narendra Ramanlal Shah as Chief Financial OfficerJD Orgochem Limited announced that Narendra Ramanlal Shah, Chief Financial Officer and Key Managerial Personnel of the Company, has tendered his resignation dated 15th December, 2020 and he will be relieved from the duties with effect from closing hours of 31st December, 2020. The company is in the process of appointing a new Chief Financial Officer and same will be communicated to the Stock Exchange in due course.お知らせ • Nov 11JD Orgochem Limited to Report Q2, 2021 Results on Nov 10, 2020JD Orgochem Limited announced that they will report Q2, 2021 results on Nov 10, 2020お知らせ • Sep 04JD Orgochem Limited to Report Q1, 2021 Results on Sep 11, 2020JD Orgochem Limited announced that they will report Q1, 2021 results on Sep 11, 2020お知らせ • Jul 17JD Orgochem Limited to Report Q4, 2020 Results on Jul 14, 2020JD Orgochem Limited announced that they will report Q4, 2020 results on Jul 14, 2020 このセクションでは通常、投資家が会社の利益創出能力を理解する一助となるよう、プロのアナリストのコンセンサス予想に基づく収益と利益の成長予測を提示する。しかし、Jaysynth Orgochem は十分な過去のデータを提供しておらず、アナリストの予測もないため、過去のデータを外挿したり、アナリストの予測を使用しても、その将来の収益を確実に算出することはできません。 シンプリー・ウォール・ストリートがカバーする企業の97%は過去の財務データを持っているため、これはかなり稀な状況です。 業績と収益の成長予測BSE:524592 - アナリストの将来予測と過去の財務データ ( )INR Millions日付収益収益フリー・キャッシュフロー営業活動によるキャッシュ平均アナリスト数12/31/20252,501121N/AN/AN/A9/30/20252,450152-93-36N/A6/30/20252,367145N/AN/AN/A3/31/20252,2801563666N/A12/31/20242,224150N/AN/AN/A9/30/20242,1431314264N/A6/30/20242,134137N/AN/AN/A3/31/20242,1181233665N/A12/31/20237-5N/AN/AN/A9/30/20235-2-38-38N/A6/30/20236-69N/AN/AN/A3/31/20231,9318143184N/A12/31/20228-64N/AN/AN/A9/30/202218-73-55-55N/A6/30/202219-8N/AN/AN/A3/31/202215-11-4-4N/A12/31/202118-7N/AN/AN/A9/30/202112-8-3-3N/A6/30/202112-8N/AN/AN/A3/31/202112-9-4-4N/A12/31/202010-13N/AN/AN/A9/30/202014-13-5-5N/A6/30/202012-13N/AN/AN/A3/31/202015-11-16-16N/A12/31/20192015N/AN/AN/A9/30/20191917N/A-17N/A6/30/20191817N/AN/AN/A3/31/20191817N/A-2N/A12/31/2018160N/AN/AN/A9/30/201816-2N/AN/AN/A6/30/2018160N/AN/AN/A3/31/2018120N/A-4N/A12/31/201712163N/AN/AN/A9/30/20177165N/AN/AN/A6/30/20175-11N/AN/AN/A3/31/20175161N/A4N/A12/31/20163-12N/AN/AN/A9/30/20163-13N/AN/AN/A6/30/20168-10N/AN/AN/A3/31/20168-9N/A-2N/A12/31/201513-7N/AN/AN/A9/30/201513-7N/AN/AN/A6/30/20158-10N/AN/AN/Aもっと見るアナリストによる今後の成長予測収入対貯蓄率: 524592の予測収益成長が 貯蓄率 ( 6.9% ) を上回っているかどうかを判断するにはデータが不十分です。収益対市場: 524592の収益がIndian市場よりも速く成長すると予測されるかどうかを判断するにはデータが不十分です高成長収益: 524592の収益が今後 3 年間で 大幅に 増加すると予想されるかどうかを判断するにはデータが不十分です。収益対市場: 524592の収益がIndian市場よりも速く成長すると予測されるかどうかを判断するにはデータが不十分です。高い収益成長: 524592の収益が年間20%よりも速く成長すると予測されるかどうかを判断するにはデータが不十分です。一株当たり利益成長率予想将来の株主資本利益率将来のROE: 524592の 自己資本利益率 が 3 年後に高くなると予測されるかどうかを判断するにはデータが不十分です成長企業の発掘7D1Y7D1Y7D1YMaterials 業界の高成長企業。View Past Performance企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2026/05/20 08:39終値2026/05/20 00:00収益2025/12/31年間収益2025/03/31データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレーク本レポートを生成するために使用した分析モデルの詳細は当社のGithubページでご覧いただけます。また、レポートの使用方法に関するガイドやYoutubeのチュートリアルも掲載しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋Jaysynth Orgochem Limited 0 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。0
Valuation Update With 7 Day Price Move • Apr 06Investor sentiment improves as stock rises 31%After last week's 31% share price gain to ₹12.63, the stock trades at a trailing P/E ratio of 14.1x. Average trailing P/E is 20x in the Chemicals industry in India. Total returns to shareholders of 166% over the past three years.
New Risk • Apr 01New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Indian stocks, typically moving 8.6% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Paying a dividend despite having no free cash flows. Share price has been volatile over the past 3 months (8.6% average weekly change). Market cap is less than US$100m (₹1.46b market cap, or US$15.7m).
Reported Earnings • Feb 23Third quarter 2026 earnings released: EPS: ₹0.17 (vs ₹0.40 in 3Q 2025)Third quarter 2026 results: EPS: ₹0.17 (down from ₹0.40 in 3Q 2025). Revenue: ₹659.4m (up 9.2% from 3Q 2025). Net income: ₹23.3m (down 57% from 3Q 2025). Profit margin: 3.5% (down from 9.0% in 3Q 2025). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 109% per year but the company’s share price has only increased by 35% per year, which means it is significantly lagging earnings growth.
Reported Earnings • Nov 13Second quarter 2026 earnings released: EPS: ₹0.37 (vs ₹0.31 in 2Q 2025)Second quarter 2026 results: EPS: ₹0.37 (up from ₹0.31 in 2Q 2025). Revenue: ₹673.8m (up 17% from 2Q 2025). Net income: ₹49.5m (up 17% from 2Q 2025). Profit margin: 7.3% (down from 7.4% in 2Q 2025). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 117% per year but the company’s share price has only increased by 30% per year, which means it is significantly lagging earnings growth.
Upcoming Dividend • Sep 08Upcoming dividend of ₹0.05 per shareEligible shareholders must have bought the stock before 12 September 2025. Payment date: 18 October 2025. Payout ratio is a comfortable 4.3% and this is well supported by cash flows. Trailing yield: 0.3%. Lower than top quartile of Indian dividend payers (1.3%). Lower than average of industry peers (0.7%).
お知らせ • Aug 25+ 2 more updatesJaysynth Orgochem Limited to Report Q3, 2026 Results on Feb 14, 2026Jaysynth Orgochem Limited announced that they will report Q3, 2026 results on Feb 14, 2026
Declared Dividend • Aug 25Dividend of ₹0.05 announcedDividend of ₹0.05 is the same as last year. Ex-date: 12th September 2025 Payment date: 19th October 2025 Dividend yield will be 0.3%, which is lower than the industry average of 0.8%. Sustainability & Growth Dividend is well covered by both earnings (4% earnings payout ratio) and cash flows (19% cash payout ratio). The company is yet to establish a track record of dividend growth or stability as it hasn't paid a regular dividend for at least 2 years. Earnings per share has grown by 32% over the last 5 years. Unless this trend reverses, it should provide support to the dividend and adequate earnings cover.
Reported Earnings • Aug 12First quarter 2026 earnings released: EPS: ₹0.13 (vs ₹0.21 in 1Q 2025)First quarter 2026 results: EPS: ₹0.13 (down from ₹0.21 in 1Q 2025). Revenue: ₹590.1m (up 17% from 1Q 2025). Net income: ₹17.2m (down 40% from 1Q 2025). Profit margin: 2.9% (down from 5.7% in 1Q 2025). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 104% per year but the company’s share price has only increased by 46% per year, which means it is significantly lagging earnings growth.
お知らせ • Aug 11Jaysynth Orgochem Limited, Annual General Meeting, Sep 19, 2025Jaysynth Orgochem Limited, Annual General Meeting, Sep 19, 2025.
お知らせ • Aug 02Jaysynth Orgochem Limited to Report Q1, 2026 Results on Aug 11, 2025Jaysynth Orgochem Limited announced that they will report Q1, 2026 results on Aug 11, 2025
Reported Earnings • May 29Full year 2025 earnings released: EPS: ₹1.16 (vs ₹0.91 in FY 2024)Full year 2025 results: EPS: ₹1.16 (up from ₹0.91 in FY 2024). Revenue: ₹2.31b (up 9.3% from FY 2024). Net income: ₹156.2m (up 27% from FY 2024). Profit margin: 6.7% (up from 5.8% in FY 2024). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 89% per year but the company’s share price has only increased by 46% per year, which means it is significantly lagging earnings growth.
お知らせ • May 28Jaysynth Orgochem Limited Recommends Dividend for the Financial Year Ended 31 March 2025Jaysynth Orgochem Limited announced that at its board meeting held on 28 May 2025, recommended the payment of dividend for the financial year ended 31 March 2025 at 5% that is INR 0.05 per equity shares having face value of INR 1 each, subject To Approve the Members at the upcoming Annual General Meeting of the Company.
お知らせ • May 19Jaysynth Orgochem Limited to Report Q4, 2025 Results on May 28, 2025Jaysynth Orgochem Limited announced that they will report Q4, 2025 results on May 28, 2025
New Risk • May 19New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Indian stocks, typically moving 8.5% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Share price has been volatile over the past 3 months (8.5% average weekly change). Market cap is less than US$100m (₹3.24b market cap, or US$37.9m).
Valuation Update With 7 Day Price Move • May 16Investor sentiment improves as stock rises 17%After last week's 17% share price gain to ₹22.24, the stock trades at a trailing P/E ratio of 20x. Average trailing P/E is 26x in the Chemicals industry in India. Total returns to shareholders of 201% over the past three years.
Reported Earnings • Feb 13Third quarter 2025 earnings released: EPS: ₹0.40 (vs ₹0.32 in 3Q 2024)Third quarter 2025 results: EPS: ₹0.40 (up from ₹0.32 in 3Q 2024). Revenue: ₹618.7m (up ₹616.4m from 3Q 2024). Net income: ₹54.6m (up ₹50.3m from 3Q 2024). Profit margin: 8.8% (down from 182% in 3Q 2024). Over the last 3 years on average, earnings per share has increased by 69% per year whereas the company’s share price has increased by 65% per year.
お知らせ • Feb 04Jaysynth Orgochem Limited to Report Q3, 2025 Results on Feb 12, 2025Jaysynth Orgochem Limited announced that they will report Q3, 2025 results on Feb 12, 2025
Valuation Update With 7 Day Price Move • Jan 20Investor sentiment improves as stock rises 16%After last week's 16% share price gain to ₹27.82, the stock trades at a trailing P/E ratio of 28.6x. Average trailing P/E is 30x in the Chemicals industry in India. Total returns to shareholders of 447% over the past three years.
お知らせ • Nov 04Jaysynth Orgochem Limited to Report Q2, 2025 Results on Nov 12, 2024Jaysynth Orgochem Limited announced that they will report Q2, 2025 results on Nov 12, 2024
Valuation Update With 7 Day Price Move • Oct 14Investor sentiment improves as stock rises 16%After last week's 16% share price gain to ₹20.35, the stock trades at a trailing P/E ratio of 20x. Average trailing P/E is 35x in the Chemicals industry in India. Total returns to shareholders of 240% over the past three years.
お知らせ • Sep 24Jaysynth Orgochem Limited Announces Cessation of Trikamdas Chandan as Independent DirectorJaysynth Orgochem Limited informed that Umesh Trikamdas Chandan (DIN: 00184677) ceased to be an Independent Director of the Company upon completion of his second term of 5 (Five) consecutive years w.e.f. closure of business hours on 23rd September, 2024.
Upcoming Dividend • Sep 11Upcoming dividend of ₹0.05 per shareEligible shareholders must have bought the stock before 18 September 2024. Payment date: 26 October 2024. Payout ratio is a comfortable 5.5% and this is well supported by cash flows. Trailing yield: 0.3%. Lower than top quartile of Indian dividend payers (1.0%). Lower than average of industry peers (0.6%).
お知らせ • Aug 29+ 1 more updateJaysynth Orgochem Limited, Annual General Meeting, Sep 26, 2024Jaysynth Orgochem Limited, Annual General Meeting, Sep 26, 2024.
Valuation Update With 7 Day Price Move • Aug 21Investor sentiment improves as stock rises 15%After last week's 15% share price gain to ₹19.35, the stock trades at a trailing P/E ratio of 19x. Average trailing P/E is 35x in the Chemicals industry in India. Total returns to shareholders of 198% over the past three years.
Buy Or Sell Opportunity • Aug 06Now 21% undervaluedOver the last 90 days, the stock has risen 25% to ₹15.66. The fair value is estimated to be ₹19.93, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 158% over the last 3 years. Meanwhile, the company has become profitable.
お知らせ • Aug 03Jaysynth Orgochem Limited to Report Q1, 2025 Results on Aug 13, 2024Jaysynth Orgochem Limited announced that they will report Q1, 2025 results on Aug 13, 2024
Buy Or Sell Opportunity • Jul 08Now 22% overvalued after recent price riseOver the last 90 days, the stock has risen 172% to ₹21.22. The fair value is estimated to be ₹17.45, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 158% over the last 3 years. Meanwhile, the company has become profitable.
Valuation Update With 7 Day Price Move • Jun 29Investor sentiment improves as stock rises 21%After last week's 21% share price gain to ₹16.80, the stock trades at a trailing P/E ratio of 18.4x. Average trailing P/E is 34x in the Chemicals industry in India. Total returns to shareholders of 433% over the past three years.
Valuation Update With 7 Day Price Move • Jun 12Investor sentiment improves as stock rises 16%After last week's 16% share price gain to ₹13.83, the stock trades at a trailing P/E ratio of 15.2x. Average trailing P/E is 32x in the Chemicals industry in India. Total returns to shareholders of 355% over the past three years.
お知らせ • May 31JD Orgochem Limited Proposes Dividend for the Financial Year Ended 31 March, 2024JD Orgochem Limited announced that Board of Directors of the Company at its Meeting held on 29th May, 2024, recommended payment of Dividend for the financial year ended 31st March, 2024 @ 5% i.e. 0.05 per equity shares having face value of 1/- each, subject To Approve the Members at the Annual General Meeting of the Company.
お知らせ • May 30Jd Orgochem Limited Announces Resignation of Bharati Ravindra Chandan and Mitesh Dilip Sejpal from the Position of Non-Executive Independent DirectorJD Orgochem Limited at its Board Meeting held on 29th May, 2024, resignation of Bharati Ravindra Chandan and Mitesh Dilip Sejpal from the position of Non-Executive Independent Director of the Company effective 29th May, 2024.
お知らせ • May 23JD Orgochem Limited to Report Q4, 2024 Results on May 29, 2024JD Orgochem Limited announced that they will report Q4, 2024 results on May 29, 2024
New Risk • May 10New major risk - Shareholder dilutionThe company's shareholders have been substantially diluted in the past year. Over 9x increase in shares outstanding. This is considered a major risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-₹38m free cash flow). Negative equity (-₹266m). Earnings have declined by 54% per year over the past 5 years. Shareholders have been substantially diluted in the past year (over 9x increase in shares outstanding). Revenue is less than US$1m (₹7.5m revenue, or US$89k). Minor Risks Share price has been volatile over the past 3 months (9.1% average weekly change). Market cap is less than US$100m (₹1.69b market cap, or US$20.3m).
お知らせ • Feb 05JD Orgochem Limited to Report Q3, 2024 Results on Feb 13, 2024JD Orgochem Limited announced that they will report Q3, 2024 results at 3:30 PM, Indian Standard Time on Feb 13, 2024
New Risk • Nov 15New major risk - Share price stabilityThe company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Indian stocks, typically moving 9.0% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-₹38m free cash flow). Share price has been highly volatile over the past 3 months (9.0% average weekly change). Negative equity (-₹266m). Earnings have declined by 61% per year over the past 5 years. Revenue is less than US$1m (₹1.0m revenue, or US$12k). Market cap is less than US$10m (₹99.8m market cap, or US$1.20m).
Reported Earnings • Nov 12Second quarter 2024 earnings released: ₹0.07 loss per share (vs ₹5.15 loss in 2Q 2023)Second quarter 2024 results: ₹0.07 loss per share (improved from ₹5.15 loss in 2Q 2023). Revenue: ₹3.70m (down 7.0% from 2Q 2023). Net loss: ₹1.03m (loss narrowed 99% from 2Q 2023). Over the last 3 years on average, earnings per share has fallen by 61% per year but the company’s share price has increased by 34% per year, which means it is well ahead of earnings.
お知らせ • Nov 01JD Orgochem Limited to Report Q2, 2024 Results on Nov 09, 2023JD Orgochem Limited announced that they will report Q2, 2024 results on Nov 09, 2023
お知らせ • Sep 28JD Orgochem Limited Appoints Maitri Bhayani as Company Secretary and Compliance OfficerJD Orgochem Limited has appointed Ms. Maitri Bhayani (Membership No. A68431) Member of Institute of Company Secretaries of India as Company Secretary and Compliance Officer of the Company with effect from 27th September, 2023. Ms. Maitri Bhayani (Membership No. A68431) is an associate member of the Institute of Company Secretaries of India and is also Commerce Graduate. She possesses over 2 years of post qualification experience. She has vast exposure in dealing with compliances of Public and Private Companies.
お知らせ • Aug 09JD Orgochem Limited, Annual General Meeting, Sep 25, 2023JD Orgochem Limited, Annual General Meeting, Sep 25, 2023.
Reported Earnings • Aug 09First quarter 2024 earnings released: ₹0.25 loss per share (vs ₹0.06 profit in 1Q 2023)First quarter 2024 results: ₹0.25 loss per share (down from ₹0.06 profit in 1Q 2023). Revenue: ₹421.0k (down 90% from 1Q 2023). Net loss: ₹3.25m (down 491% from profit in 1Q 2023). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 99 percentage points per year, which is a significant difference in performance.
お知らせ • Aug 01JD Orgochem Limited to Report Q1, 2024 Results on Aug 08, 2023JD Orgochem Limited announced that they will report Q1, 2024 results on Aug 08, 2023
お知らせ • May 06JD Orgochem Limited to Report Q4, 2023 Results on May 12, 2023JD Orgochem Limited announced that they will report Q4, 2023 results on May 12, 2023
お知らせ • Feb 11JD Orgochem Limited Announces Resignation of Shivani S. Kawle as Company Secretary and Compliance Officer, Effective March 31, 2023JD Orgochem Limited announced that Ms. Shivani S. Kawle has tendered her resignation from the post of Company Secretary and Compliance Officer (Key Managerial Personnel) of the Company. The Company has accepted her resignation and relieved her from duties with effect from close of business hours of 31st March, 2023. She tendered her resignation to pursue opportunities outside the Company.
お知らせ • Feb 03JD Orgochem Limited to Report Q3, 2023 Results on Feb 10, 2023JD Orgochem Limited announced that they will report Q3, 2023 results on Feb 10, 2023
お知らせ • Jan 26JD Orgochem Limited (BSE:524592) entered into a scheme of implementation to acquire Jaysynth Dyestuff (India) Limited and Jaysynth Impex Private Limited.JD Orgochem Limited (BSE:524592) entered into a scheme of implementation to acquire Jaysynth Dyestuff (India) Limited and Jaysynth Impex Private Limited on January 24, 2023. As per the terms, JD Orgochem will issue 14 fully paid up equity shares JD Orgochem allotted for every 1 share held by the Equity Shareholders of Jaysynth Dyestuff (India) Limited, and 252 fully paid up 2% Redeemable Non-convertible Non-Cumulative Non-Participating Preference Shares of JD Orgochem to be issued and allotted for every 1 each held by the Equity Shareholders of Jaysynth Impex Private.
Board Change • Nov 17Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 4 experienced directors. 2 highly experienced directors. Whole Time Director Suhas Jande was the last director to join the board, commencing their role in 2019. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.
お知らせ • Nov 03JD Orgochem Limited to Report Q2, 2023 Results on Nov 10, 2022JD Orgochem Limited announced that they will report Q2, 2023 results on Nov 10, 2022
お知らせ • Jul 30JD Orgochem Limited to Report Q1, 2023 Results on Aug 08, 2022JD Orgochem Limited announced that they will report Q1, 2023 results at 12:00 PM, Indian Standard Time on Aug 08, 2022
お知らせ • Jul 13JD Orgochem Limited, Annual General Meeting, Aug 08, 2022JD Orgochem Limited, Annual General Meeting, Aug 08, 2022, at 15:00 Indian Standard Time.
お知らせ • May 21JD Orgochem Limited to Report Q4, 2022 Results on May 30, 2022JD Orgochem Limited announced that they will report Q4, 2022 results on May 30, 2022
Board Change • Apr 27Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 6 experienced directors. No highly experienced directors. Whole Time Director Suhas Jande was the last director to join the board, commencing their role in 2019. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.
Board Change • Apr 02Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 6 experienced directors. No highly experienced directors. Whole Time Director Suhas Jande was the last director to join the board, commencing their role in 2019. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.
Reported Earnings • Feb 13Third quarter 2022 earnings: Revenues and EPS in line with analyst expectationsThird quarter 2022 results: ₹0.13 loss per share (up from ₹0.24 loss in 3Q 2021). Revenue: ₹9.46m (up 224% from 3Q 2021). Net loss: ₹1.81m (loss narrowed 42% from 3Q 2021). Revenue was in line with analyst estimates. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 94 percentage points per year, which is a significant difference in performance.
お知らせ • Feb 11JD Orgochem Limited Announces Appointment of Shivani Shailesh Kawle as Company Secretary and Compliance OfficerJD Orgochem Limited announced at the board meeting held on February 10, 2022 that the company approved appointment Ms. Shivani Shailesh Kawle Member of Institute of Company Secretaries of India as Company Secretary and Compliance Officer of the Company with effect from 10 February, 2022.
お知らせ • Feb 03JD Orgochem Limited to Report Q3, 2022 Results on Feb 10, 2022JD Orgochem Limited announced that they will report Q3, 2022 results on Feb 10, 2022
Reported Earnings • Jul 04Full year 2021 earnings released: ₹0.67 loss per share (vs ₹0.86 loss in FY 2020)The company reported a solid full year result with reduced losses, improved revenues and improved control over expenses. Full year 2021 results: Revenue: ₹19.8m (up 32% from FY 2020). Net loss: ₹8.52m (loss narrowed 25% from FY 2020). Over the last 3 years on average, earnings per share has fallen by 61% per year but the company’s share price has increased by 7% per year, which means it is well ahead of earnings.
Is New 90 Day High Low • Feb 18New 90-day low: ₹2.81The company is down 6.0% from its price of ₹2.99 on 19 November 2020. The Indian market is up 21% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 15% over the same period.
お知らせ • Feb 13JD Orgochem Limited Announces Appointment of Kantibhai Maganbhai Darji as Chief Financial Officer and Key Managerial PersonnelJD Orgochem Limited announced that at its Board meeting held on 11th February, 2021, approved the appointment of Kantibhai Maganbhai Darji as Chief Financial Officer and Key Managerial Personnel of the Company. Mr. Kantibhai Maganbhai Darji has been appointed as Chief Financial Officer (CFO)and Key Managerial Personnel (KMP) of the Company with effect from 11th February, 2021. Mr. Kantibhai Maganbhai Darji is a commerce graduate & possesses over 30 years of experience across various fields such as banking, finance, fund management, budgeting etc. He is well conversant with the industry, commerce and trade.
お知らせ • Feb 02JD Orgochem Limited to Report Q3, 2021 Results on Feb 11, 2021JD Orgochem Limited announced that they will report Q3, 2021 results on Feb 11, 2021
Is New 90 Day High Low • Dec 23New 90-day high: ₹3.13The company is up 4.0% from its price of ₹3.02 on 18 September 2020. The Indian market is up 19% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 18% over the same period.
お知らせ • Dec 18JD Orgochem Limited Announces the Resignation of Narendra Ramanlal Shah from Key Managerial PersonnelJD Orgochem Limited announced that Narendra Ramanlal Shah, Chief Financial Officer and Key Managerial Personnel of the Company, has tendered his resignation dated 15th December, 2020 and he will be relieved from the duties with effect from closing hours of 31st December, 2020. The company is in the process of appointing a new Chief Financial Officer and same will be communicated to the Stock Exchange in due course.
お知らせ • Dec 17JD Orgochem Limited Announces the Resignation of Narendra Ramanlal Shah as Chief Financial OfficerJD Orgochem Limited announced that Narendra Ramanlal Shah, Chief Financial Officer and Key Managerial Personnel of the Company, has tendered his resignation dated 15th December, 2020 and he will be relieved from the duties with effect from closing hours of 31st December, 2020. The company is in the process of appointing a new Chief Financial Officer and same will be communicated to the Stock Exchange in due course.
お知らせ • Nov 11JD Orgochem Limited to Report Q2, 2021 Results on Nov 10, 2020JD Orgochem Limited announced that they will report Q2, 2021 results on Nov 10, 2020
お知らせ • Sep 04JD Orgochem Limited to Report Q1, 2021 Results on Sep 11, 2020JD Orgochem Limited announced that they will report Q1, 2021 results on Sep 11, 2020
お知らせ • Jul 17JD Orgochem Limited to Report Q4, 2020 Results on Jul 14, 2020JD Orgochem Limited announced that they will report Q4, 2020 results on Jul 14, 2020